肯尼亚内罗毕无接触新生儿生理监测仪评估
该研究在肯尼亚四轮前瞻性评估中,将EarlySense床垫下设备与Masimo Rad-97参考设备比较新生儿心率和呼吸率测量准确性。最终轮次心率偏差-0.8次/分、呼吸率偏差1.6次/分,一致性达到预设30%阈值,但需进一步研究成本效果和临床效果。
要点
- EarlySense与Masimo设备在新生儿心率和呼吸率测量上一致性可接受。
- 最终轮次心率偏差-0.8次/分,呼吸率偏差1.6次/分。
- 大规模应用前需进一步评估成本效果和临床效果。
核心结论
- 在受试者内变异性大的背景下,EarlySense与Masimo多参数连续生理监测设备之间的一致性可接受。
- 在新生儿中大规模实施EarlySense设备前,仍需进一步研究其成本效果和临床效果。
研究设计与样本
- 在四轮评估中,前瞻性比较EarlySense床垫下设备与Masimo Rad-97脉搏血氧仪(带二氧化碳描记)参考设备在肯尼亚新生儿中心率和呼吸率测量上的准确性。
- 每轮评估随机选取200个数据时段,使用Bland-Altman图和20%区域的Clarke误差网格进行比较。
- 2019年7月9日至2020年1月8日期间,从76名入组新生儿中收集了280小时的多参数连续生理监测数据。
主要发现
- 最终评估轮次中,EarlySense设备心率偏差为-0.8次/分,呼吸率偏差为1.6次/分。
- 最终评估轮次中,心率95%一致性界限上下限之间的归一化跨度为6.2%,呼吸率为27.3%。
- 两种设备之间的一致性达到了预设的30%阈值。
- Clarke误差网格显示,心率所有观测值和呼吸率197/200观测值均在20%差异范围内。
临床怎么用
- 在资源有限地区,EarlySense无接触监测设备可提供与参考设备可接受一致的心率和呼吸率测量。
- 临床使用前需考虑该设备在新生儿中的成本效果和临床效果尚未确立。
局限性
- 研究未报告成本效果和临床效果数据,需进一步研究后方可大规模实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Globally, 2.5 million neonates died in 2018, accounting for 46% of under-5 deaths. Multiparameter continuous physiological monitoring (MCPM) of neonates allows for early detection and treatment of life-threatening health problems. However, neonatal monitoring technology is largely unavailable in low-resource settings. METHODS: In four evaluation rounds, we prospectively compared the accuracy of the EarlySense under-mattress device to the Masimo Rad-97 pulse CO-oximeter with capnography reference device for heart rate (HR) and respiratory rate (RR) measurements in neonates in Kenya. EarlySense algorithm optimisations were made between evaluation rounds. In each evaluation round, we compared 200 randomly selected epochs of data using Bland-Altman plots and generated Clarke error grids with zones of 20% to aid in clinical interpretation. RESULTS: Between 9 July 2019 and 8 January 2020, we collected 280 hours of MCPM data from 76 enrolled neonates. At the final evaluation round, the EarlySense MCPM device demonstrated a bias of -0.8 beats/minute for HR and 1.6 breaths/minute for RR, and normalised spread between the 95% upper and lower limits of agreement of 6.2% for HR and 27.3% for RR. Agreement between the two MCPM devices met the a priori-defined threshold of 30%. The Clarke error grids showed that all observations for HR and 197/200 for RR were within a 20% difference. CONCLUSION: Our research indicates that there is acceptable agreement between the EarlySense and Masimo MCPM devices in the context of large within-subject variability; however, further studies establishing cost-effectiveness and clinical effectiveness are needed before large-scale implementation of the EarlySense MCPM device in neonates. TRIAL REGISTRATION NUMBER: NCT03920761.
引用
- Wang D, Macharia WM, Ochieng R, et al. Evaluation of a contactless neonatal physiological monitor in Nairobi, Kenya. Arch Dis Child. 2021. PMID: 34740876. doi:10.1136/archdischild-2021-322344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。